Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB077699

Prostatic Acid Phosphatase/ACPP Antibody (202), DyLight 405
SDP

Catalog No. NB077699 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB077699 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB077699 Supplier Novus Biologicals Supplier No. NBP290772V

Description

Rabbit Monoclonal Antibody

Prostatic Acid Phosphatase/ACPP Monoclonal specifically detects Prostatic Acid Phosphatase/ACPP in Mouse samples. It is validated for ELISA.

Specifications

Antigen Prostatic Acid Phosphatase/ACPP
Applications ELISA
Classification Monoclonal
Clone 202
Conjugate DyLight 405
Formulation 50 mM Sodium Borate
Gene Alias acid phosphatase, prostate, ACP3, ACP-3, EC 3.1.3.2, PAP, prostatic acid phosphatase, prostatic acid phosphotase
Host Species Rabbit
Immunogen This antibody was obtained from a rabbit immunized with purified, recombinant Mouse Prostatic Acid Phosphatase/ACPP (Q8CE08-1; Met1-Arg381).
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Cell Cycle and Replication
Primary or Secondary Primary
Gene ID (Entrez) 55
Test Specificity No cross-reactivity in ELISA with: Mouse ACP5
Target Species Mouse
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.